Helen Tayton-Martin, Ph.D., M.B.A, Adaptimmune Co-Founder and Chief Business & Strategy Officer, will step down from the Company March 31, 2025 Gavin Wood, Chief Financial Officer, will step down from the Company May 31, 2025 Philadelphia, Pennsylvania and Oxford, United Kingdom–(Newsfile Corp. – December 19, 2024) – Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company working […]